BPC-157 / TB-500 Blend
10mg/vial (5mg+5mg)
Dual-action regenerative blend combining BPC-157 and TB-500 for synergistic tissue repair research.
Price per vial
$109.99
10mg/vial (5mg+5mg)
Concentration
10mg/vial (5mg+5mg)
Warehouse
US Domestic
Product Description
This blend combines BPC-157 and TB-500 (Thymosin Beta-4 fragment) in equimolar ratios for research into their synergistic effects on tissue regeneration, inflammation resolution, and wound healing.
Research Overview
BPC-157 and TB-500 operate through complementary but distinct mechanisms—BPC-157 primarily via growth factor receptor upregulation and NO pathways, while TB-500 acts through actin polymerization (G-actin sequestration) and VEGF upregulation. Research combining both compounds has examined enhanced angiogenesis, accelerated wound closure, and multi-tissue repair synergy. For laboratory research use only.
Research Applications
Research Use Only
This product is intended solely for laboratory research and analytical purposes. Not for human consumption or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA.